Business Description
Fusen Pharmaceutical Co Ltd
ISIN : KYG370981030
Share Class Description:
HKSE:01652: Ordinary SharesCompare
Compare
Traded in other countries / regions
01652.Hong Kong IPO Date
2018-07-11Description
Fusen Pharmaceutical Co Ltd is engaged in manufacturing shuanghuanglian based cold medicine. The product portfolio company includes shuanghuanglian based cold medicines which include oral solutions and shuanghuanglian injections, other PCM and western medicine products which include compound ferrous sulphate granules and flunarizine hydrochloride capsules.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 0.67 | |||||
| Debt-to-EBITDA | -4.25 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.06 | |||||
| Beneish M-Score | -2.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.1 | |||||
| 3-Year EBITDA Growth Rate | -44.6 | |||||
| 3-Year Book Growth Rate | -6.4 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.37 | |||||
| 9-Day RSI | 52.81 | |||||
| 14-Day RSI | 51.48 | |||||
| 6-1 Month Momentum % | 14.94 | |||||
| 12-1 Month Momentum % | -33.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.73 | |||||
| Quick Ratio | 0.53 | |||||
| Days Inventory | 244.33 | |||||
| Days Sales Outstanding | 67.59 | |||||
| Days Payable | 249.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 1.3 | |||||
| Shareholder Yield % | -10.15 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.17 | |||||
| Operating Margin % | -12.05 | |||||
| Net Margin % | -21.09 | |||||
| FCF Margin % | -29.77 | |||||
| ROE % | -15.74 | |||||
| ROA % | -6.73 | |||||
| ROIC % | -3.73 | |||||
| ROC (Joel Greenblatt) % | -15.86 | |||||
| ROCE % | -12.47 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.59 | |||||
| PB Ratio | 1.3 | |||||
| Price-to-Tangible-Book | 1.38 | |||||
| EV-to-EBIT | -12.53 | |||||
| EV-to-EBITDA | -12.53 | |||||
| EV-to-Revenue | 2.41 | |||||
| EV-to-FCF | -8.14 | |||||
| Price-to-Projected-FCF | 2.54 | |||||
| Earnings Yield (Greenblatt) % | -7.98 | |||||
| FCF Yield % | -18.79 | |||||
| Forward Rate of Return (Yacktman) % | -44.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fusen Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 462.011 | ||
| EPS (TTM) (HK$) | -0.131 | ||
| Beta | 0.25 | ||
| Volatility % | 50.78 | ||
| 14-Day RSI | 51.48 | ||
| 14-Day ATR (HK$) | 0.055306 | ||
| 20-Day SMA (HK$) | 0.982 | ||
| 12-1 Month Momentum % | -33.33 | ||
| 52-Week Range (HK$) | 0.75 - 1.56 | ||
| Shares Outstanding (Mil) | 739.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Fusen Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Fusen Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Fusen Pharmaceutical Co Ltd Frequently Asked Questions
What is Fusen Pharmaceutical Co Ltd(HKSE:01652)'s stock price today?
The current price of HKSE:01652 is HK$0.99. The 52 week high of HKSE:01652 is HK$1.56 and 52 week low is HK$0.75.
When is next earnings date of Fusen Pharmaceutical Co Ltd(HKSE:01652)?
The next earnings date of Fusen Pharmaceutical Co Ltd(HKSE:01652) is .
Does Fusen Pharmaceutical Co Ltd(HKSE:01652) pay dividends? If so, how much?
Fusen Pharmaceutical Co Ltd(HKSE:01652) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers